Onal, C. Et Al. 2021. Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.. Clinical nuclear medicine , vol.46, no.6 , 465-470.

Onal, C., ÖZYİĞİT, G., Akgun, Z., Atalar, B., Igdem, S., Oymak, E., ... AGAOGLU, F.(2021). Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.. Clinical nuclear medicine , vol.46, no.6, 465-470.

Onal, Cem Et Al. "Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.," Clinical nuclear medicine , vol.46, no.6, 465-470, 2021

Onal, Cem Et Al. "Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.." Clinical nuclear medicine , vol.46, no.6, pp.465-470, 2021

Onal, C. Et Al. (2021) . "Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.." Clinical nuclear medicine , vol.46, no.6, pp.465-470.

@article{article, author={Cem Onal Et Al. }, title={Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.}, journal={Clinical nuclear medicine}, year=2021, pages={465-470} }